Funding agencies: This study was supported by an unrestricted research grant from Kyowa Hakko Kirin, Co. Ltd., Tokyo, Japan.
Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease
Version of Record online: 11 MAR 2013
Copyright © 2013 Movement Disorder Society
Volume 28, Issue 8, pages 1138–1141, July 2013
How to Cite
Mizuno, Y., Kondo, T. and the Japanese Istradefylline Study Group (2013), Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease. Mov. Disord., 28: 1138–1141. doi: 10.1002/mds.25418
This study was supported by Kyowa Hakko Kirin Co., Ltd., Japan.
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the Acknowledgments section online.
- Issue online: 12 AUG 2013
- Version of Record online: 11 MAR 2013
- Manuscript Accepted: 28 JAN 2013
- Manuscript Revised: 24 JAN 2013
- Manuscript Received: 6 NOV 2012
Additional Supporting Information may be found in the online version of this article.
Supplementary Figure 1. Subject flow diagram.
Supplementary Figure 2. Clinical Global Impression - global improvement at endpoint (full analysis set)
|mds25418-sup-0002-supptable.doc||62K||Supplementary Table 1. Treatment emergent adverse events reported in 3% or more of subjects|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.